Detalhe da pesquisa
1.
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Liver Int
; 44(6): 1343-1350, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436529
2.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Oncologist
; 28(7): e526-e533, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023703
3.
Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
Hepatol Res
; 53(3): 238-246, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433862
4.
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
Hepatol Res
; 53(1): 51-60, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136893
5.
The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.
Dig Dis
; 40(5): 625-634, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808618
6.
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.
Hepatol Res
; 52(3): 269-280, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761470
7.
Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration.
Dig Dis
; 39(3): 225-233, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731217
8.
Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
Dig Dis
; 39(3): 234-242, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759604
9.
Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course.
Hepatol Res
; 51(2): 239-244, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978866
12.
Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases.
Hepatology
; 71(2): 757-759, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31429969
13.
Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment.
BMC Cancer
; 16(1): 878, 2016 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27835949
14.
Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B.
BMC Gastroenterol
; 16: 38, 2016 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26987437
15.
Recessive inheritance of population-specific intronic LINE-1 insertion causes a rotor syndrome phenotype.
Hum Mutat
; 36(3): 327-32, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25546334
16.
No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis.
Drug Metab Dispos
; 43(5): 691-7, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25713208
17.
Effects of ethanol and acetaldehyde load on erythrocyte deformability in healthy subjects and patients with liver cirrhosis.
Nihon Arukoru Yakubutsu Igakkai Zasshi
; 50(1): 13-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26027411
18.
Low-grade Appendiceal Mucinous Neoplasm with Appendiceal Reduction and Re-expansion Over a Two-year Period: A Case Report.
Intern Med
; 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369352
19.
Ectopic Adrenocorticotropic Hormone Syndrome due to Pancreatic Neuroendocrine Carcinoma: A Case Report.
Intern Med
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38811222
20.
Meloxicam as an adjuvant to peginterferon-α-2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial.
Hepatol Res
; 43(9): 925-32, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23356876